Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19193301 | 0.92 | KMT2A (0.45) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL16137631 | 0.92 | MEN1 (0.45) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL16137525 | 0.89 | MEN1 (0.46) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL16137527 | 0.85 | ESR1 (0.42) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL15356195 | 0.85 | ESR1 (0.49) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL17248000 | 0.85 | MEN1 (0.39) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL25002687 | 0.84 | MEN1 (0.41) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL26451117 | 0.83 | MEN1 (0.37) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL25002527 | 0.82 | ESR1 (0.39) | MEN1KMT2AMAPTKDM4ELMNA | |
| SCHEMBL18386025 | 0.82 | MEN1 (0.41) | MEN1KMT2AMAPTKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230056225-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-02-23 | — | — | US | disclosed |
| US-10829662-B2 | Curable composition, cured product, cured film, display panel, and method for producing cured product | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-11-10 | — | — | US | disclosed |
| US-20200139433-A1 | METHOD FOR PRODUCING SURFACE-MODIFIED METAL OXIDE FINE PARTICLE, METHOD FOR PRODUCING IMPROVED METAL OXIDE FINE PARTICLES, SURFACE-MODIFIED METAL OXIDE FINE PARTICLES, AND METAL OXIDE FINE PARTICLE DISPERSION LIQUID | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-05-07 | — | — | US | disclosed |
| US-10640607-B2 | Curable composition, cured film, display panel, and method for producing cured product | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-05-05 | — | — | US | disclosed |
| US-10479879-B2 | Curable composition, cured product of the curable composition, and method of producing a cured product using the curable composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-11-19 | — | — | US | disclosed |
| US-10233269-B2 | Compound containing structural unit derived from vinyl ether compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-03-19 | — | — | US | disclosed |
| US-20190031818-A1 | CURABLE COMPOSITION, CURED FILM, DISPLAY PANEL OR OLED LIGHT, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-01-31 | — | — | US | disclosed |
| US-9914687-B2 | Composition containing vinyl-group-containing compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-03-13 | — | — | US | disclosed |
| US-9914687-B2 | Composition containing vinyl-group-containing compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-03-13 | — | — | US | disclosed |
| US-9902675-B2 | Vinyl-group-containing fluorene compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2018-02-27 | — | — | US | disclosed |
| EP-2930200-A1 | Curable composition, adhesive, method of producing fiber-reinforced composite material, and fiber-reinforced composite material | TOKYO OHKA KOGYO CO., LTD. (JP) | 2015-10-14 | — | — | EP | disclosed |
| US-20150252229-A1 | CURABLE COMPOSITION, ADHESIVE, METHOD OF PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL, AND FIBER-REINFORCED COMPOSITE MATERIAL | TOKYO OHKA KOGYO CO., LTD. (JP) | 2015-09-10 | — | — | US | disclosed |
| US-20150252229-A1 | CURABLE COMPOSITION, ADHESIVE, METHOD OF PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL, AND FIBER-REINFORCED COMPOSITE MATERIAL | TOKYO OHKA KOGYO CO., LTD. (JP) | 2015-09-10 | — | — | US | disclosed |
| WO-2014157675-A1 | COMPOSITION CONTAINING VINYL-GROUP-CONTAINING COMPOUND | 東京応化工業株式会社 (JP) | 2014-10-02 | — | — | WO | disclosed |
| US-20140287219-A1 | OPTICAL ELEMENT MATERIAL AND METHOD FOR PRODUCING SAME | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2014-09-25 | — | — | US | disclosed |
| US-20140287219-A1 | OPTICAL ELEMENT MATERIAL AND METHOD FOR PRODUCING SAME | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2014-09-25 | — | — | US | disclosed |
| US-20130288021-A1 | RESIN COMPOSITION FOR PHOTOIMPRINTING, PATTERN FORMING PROCESS AND ETCHING MASK | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2013-10-31 | — | — | US | disclosed |
| US-20130288021-A1 | RESIN COMPOSITION FOR PHOTOIMPRINTING, PATTERN FORMING PROCESS AND ETCHING MASK | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2013-10-31 | — | — | US | disclosed |
| WO-2013018302-A1 | METHOD FOR PRODUCING AROMATIC VINYL ETHER | 丸善石油化学株式会社 (JP) | 2013-02-07 | — | — | WO | disclosed |
| US-20090068569-A1 | Resin composition for hologram recording material, hologram recording material, and method for producing hologram recording medium | NIPPON PAINT CO., LTD. | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10233269-B2 | Compound containing structural unit derived from vinyl ether compound | CHRM1, CYP1A1, CCNA1 | MEN1 646/4885KMT2A 260/4885MAPT 3423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.